Hims & Hers Health (HIMS) Short-Term Debt repayments (2021)
Hims & Hers Health's (HIMS) quarterly Short-Term Debt repayments came in at $1.2 million in Q1 2021.
Hims & Hers Health (HIMS) Short-Term Debt repayments (2021) Analysis & Trends
Hims & Hers Health has disclosed Short-Term Debt repayments across 1 years of filings, most recently posting $1.2 million for Q1 2021.
- Short-Term Debt repayments for Q1 2021 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $1.2 million (changed N/A YoY), and the FY2021 annual result was $1.2 million, changed N/A from the prior year.
- Short-Term Debt repayments came in at $1.2 million for Q1 2021 at Hims & Hers Health.
- In the past five years, Short-Term Debt repayments ranged from a high of $1.2 million in Q1 2021 to a low of $1.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.19 Mn |
| Mar 31, 2021 | 1.19 Mn |